Overview

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The use of prophylaxis for venous thromboembolism (VTE) remains grossly underused for women who undergo gynecologic surgery for benign conditions world wide and especially in developing countries including our region. Having a research in our locality for the first time might raise awareness of the importance of VTE prophylaxis.
Phase:
N/A
Details
Lead Sponsor:
Hawler Medical University
Treatments:
Bemiparin
Heparin, Low-Molecular-Weight